Ifp Advisors, Inc Y M Abs Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 334 shares of YMAB stock, worth $2,875. This represents 0.0% of its overall portfolio holdings.
Number of Shares
334
Previous 0
Infinity%
Holding current value
$2,875
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding YMAB
# of Institutions
8Shares Held
3.29MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.94MShares$25.3 Million0.0% of portfolio
-
Memorial Sloan Kettering Cancer Center New York, NY191KShares$1.65 Million4.24% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL112KShares$968,4780.0% of portfolio
-
Ziegler Capital Management, LLC35.5KShares$305,3190.02% of portfolio
-
Skopos Labs, Inc. Riverhead, NY16.1KShares$138,2850.02% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $376M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...